Methods of preparing cytotoxic benzodiazepine derivatives

US9890179B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9890179-B2
Application numberUS-201615216517-A
CountryUS
Kind codeB2
Filing dateJul 21, 2016
Priority dateJul 21, 2015
Publication dateFeb 13, 2018
Grant dateFeb 13, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of preparing a compound of formula (17a): or a salt thereof, said method comprising reacting a compound of formula (14a) with a monomer compound of formula (d 1 ), wherein X 3 is —Cl; P 3 is H or an amine protecting group; and R 101 is (C 1 -C 3 )alkyl, pyridyl, or nitropyridyl. 2. The method of claim 1 , wherein the compound of formula (14a) is reacted with a monomer of formula (d 1 ) in the presence of an alcohol activating agent and an azodicarboxylate. 3. The method of claim 2 , wherein the alcohol activating agent is triphenylphosphine. 4. The method of claim 2 , wherein the azodicarboxylate is selected from the group consisting of: diethyl azodicarboxylate (DEAD), diisopropyl azodicarboxylate (DIAD), 1,1′-(azodicarbonyl)dipiperidine (ADDP), and ditertbutyl azodicarboxylate (DTAD). 5. The method of claim 2 , wherein the compound of formula (14a) is reacted with the monomer compound of formula (d 1 ), wherein P 3 is H, to form a compound of formula (17a′): 6. The method of claim 2 , wherein P 3 is an amine protecting group and the method further comprises the step of reacting the compound of formula (17a) with an amine deprotecting reagent to form a compound of formula (17a′): 7. A method of preparing a compound of formula (18a), or a pharmaceutically acceptable salt thereof, said method comprising reacting a compound of formula of (17a): with a monomer of formula (a 1 ): wherein X 3 is —Cl; P 3 is H or an amine protecting group; and R 101 is (C 1 -C 3 )alkyl, pyridyl, or nitropyridyl. 8. The method of claim 7 , wherein the compound of formula (17a) is reacted with a monomer compound of formula (a 1 ) in the presence of a base. 9. The method of claim 8 , wherein the base is sodium carbonate, potassium carbonate, cesium carbonate, sodium hydride, or potassium hydride. 10. The method of claim 9 , wherein the base is potassium carbonate. 11. The method of claim 8 , wherein the compound of formula (17a) is reacted with a monomer compound of formula (a 1 ) in the presence of a polar aprotic solvent. 12. The method of claim 11 , wherein the polar aprotic solvent is dimethylformamide or dimethylacetamide. 13. The method of claim 8 , wherein the compound of formula (17a) is reacted with monomer of formula (a 1 ), wherein P 3 is H, to form a compound of formula (Ia′): 14. The method of claim 8 , wherein P 3 is an amine protecting group and the compound of formula (18a) is further reacted with an amine deprotecting reagent to form a compound of formula (Ia′): 15. A method of preparing a compound of formula (18a), or a pharmaceutically acceptable salt thereof, said method comprising the steps of: (1) reacting the compound of formula (14a): or a salt thereof, with a reduced monomer compound of formula (d 1 ), in the presence of an alcohol activating agent to form a compound of formula (17a): or a salt thereof; and (2) reacting the compound of formula of (17a) with a monomer of formula (a 1 ): to form a compound of formula (18a), or a pharmaceutically acceptable salt thereof, wherein X 3 is —Cl; P 1 is an alcohol protecting group; P 3 is H or an amine protecting group; and R 101 is (C 1 -C 3 )alkyl, pyridyl, or nitropyridyl. 16. The method of claim 15 , wherein the compound of formula (17a) is reacted with monomer of formula (a 1 ), wherein P 3 is H, to form a compound of formula (Ia′): 17. The method of claim 15 , wherein P 3 is an amine protecting group and the compound of formula (18a) is further reacted with an amine deprotecting reagent to form a compound of formula (Ia′): 18. The method of claim 15 , wherein the compound of formula (14a) or a salt thereof is prepared a method comprising the following steps: (1) reacting a chlorinating reagent with a compound of formula (2a), to form a compound a compound of formula (13a), or a salt thereof; (2) reacting the compound of formula (13a) with an alcohol deprotecting reagent to form the compound of formula (14a) or a salt thereof. 19. The method of claim 18 , wherein the compound of formula (2a) is prepared by reacting a compound of formula (1a) with an alcohol protecting reagent

Assignees

Inventors

Classifications

  • Antineoplastic agents · CPC title

  • C07C303/28Primary

    by reaction of hydroxy compounds with sulfonic acids or derivatives thereof · CPC title

  • C07D487/04Primary

    Ortho-condensed systems · CPC title

  • and aliphatic · CPC title

  • C07D519/00Primary

    Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9890179B2 cover?
The invention relates to novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
Who is the assignee on this patent?
Immunogen Inc
What technology area does this patent fall under?
Primary CPC classification C07C303/28. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).